Compare Extra Space Storage, Inc. (EXR) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs Pfizer Inc — how do they compare? Extra Space Storage, Inc. trades at $150.27 (market cap $30.56B), while Pfizer Inc trades at $25.11 (market cap $141.46B). The key difference: Pfizer Inc is far larger — about 4.6× Extra Space Storage, Inc.'s market cap, and Pfizer Inc pays the higher dividend (6.93%). Which is the better fit depends on your goals.
| EXR | PFE | |
|---|---|---|
Market Cap | $30.56B | $141.46B |
Sector | Real Estate | Health |
52-Week High | $152.75 | $28.56 |
52-Week Low | $126.67 | $23.29 |
Enterprise Value | $44.36B | $192.12B |
Dividend Yield | 4.48% | 6.93% |
Volume | — | 29,869,932 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EXR trades at $148.89, up 2.33% over 24 hours, with a neutral technical signal and bullish moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.14 exceeding expectations. Revenue reached $3.38B in 2025, with a net income margin of 27.66%, though ROE remains modest at 6.92%. Recent news highlights steady expansion and a $550 million senior notes issuance, while analyst consensus is a $155.88 price target with a mix of Buy and Hold ratings.
Outlook is cautiously optimistic given consistent earnings performance and resilient demand, but risks include high debt levels, competitive pressures, and expense growth outpacing revenue. The stock's valuation metrics like P/E of 32.5 suggest it is priced for growth, yet investor sentiment is divided, with technical indicators showing neutral momentum near key support at $144.
Pfizer (PFE) trades at $25.14, up 3.67% in the last session, with a bullish technical signal despite mixed momentum indicators. The company maintains solid profitability with a net margin of 11.83% and has beaten earnings estimates for three consecutive quarters. Recent news highlights pipeline advancements in oncology and obesity treatments, positioning Pfizer for potential growth catalysts in 2026.
The stock presents a value opportunity with a P/E of 18.95 below industry averages, supported by a stable dividend yield. Key risks include patent expirations and revenue volatility post-COVID. Analyst consensus is mixed with a $28.25 price target, suggesting moderate upside from current levels amid cautious optimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
